Dr. Varsha Thakoersing is the CEO of IMcoMET. They have developed a technology that allows access and control of fluid around cells, called interstitial fluid. This fluid contains many biomarkers that provide detailed information about both the local tissue condition and general health status of an individual.  

They are integrating our M-Duo Technology® into a set of tools to improve skin cancer diagnostics and skin cancer research to drive personalized medicine and biomedical research forward. Both with the ultimate goal to improve therapy outcomes for skin cancer patients.

Dr. Peter Rahfeld is the CSO and co-founder of Avivobio, a canadian startup that focuses on removing the blood-type barrier in organ donations. As anyone who has donated blood before knows, there are different types and not everyone can get everyone's blood. The case is even more severe in organ donation, where the donor has to be selected carefully to not be rejected by the body. In their company, they develop technology to make organs and blood more accepted by recipients.  

Dr. Alina Rwei is a researcher at TU Delft with a focus on engineering new diagnostic tools and wearables. She obtained her PhD in material sciences at MIT and has since switched to the department of chemical engineering at TU Delft to form her own group. She will be excited to tell you about how she ended up at chemical engineering, what devices she envisions us to wear and how she involves her family in her research.

In the near future the ground floor of Langegracht 70 will also be part of PLNT. Space for new offices and a space for creators, but before the rebuild will go full throttle, WE will be able to go full throttle with a game of lasers!

So grab your opportunity to fire at your colleagues, friends, newest acquaintances, rivals or future business partners and network like you've never networked before!

Of course you may also enjoy our promised free drinks. ;)